Back
Pyxis Oncology 10K Form
Sell
42
PYXS
Pyxis Oncology
Last Price:
$1.35
Seasonality Move:
-6.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PYXS News And Ratings
See the #1 stock for the next 7 days that we like better than PYXS
PYXS Financial Statistics
Sales & Book Value
| Annual Sales: | $16.1M |
|---|---|
| Cash Flow: | $-22.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.67 |
| Price / Book: | 0.81 |
Profitability
| EPS (TTM): | -1.58000 |
|---|---|
| Net Income (TTM): | $-95.2M |
| Gross Margin: | $15.7M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Pyxis Oncology Earnings Forecast
Key Pyxis Oncology Financial Ratios
-
The Gross Profit Margin over the past 2 years for PYXS is 97.06%.
-
The Selling, General & Administrative Expenses for PYXS have been equal to 157.44% of Gross Profit Margin.
-
The Research & Development expenses have been 363.85% of Revenue.
-
The Net Earning history of PYXS is -478.95% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Pyxis Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PYXS |
| Website: | pyxisoncology.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.19 |
| Quick Ratio: | 11.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PYXS Technical Analysis vs Fundamental Analysis
Sell
42
Pyxis Oncology (PYXS)
is a Sell
Is Pyxis Oncology a Buy or a Sell?
-
Pyxis Oncology stock is rated a SellThe current Pyxis Oncology [PYXS] share price is $1.35. The Score for PYXS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.